Entrada Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRDA and other ETFs, options, and stocks.

About TRDA

Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company’s Endosomal Escape Vehicle (EEV) therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index.

CEO

Dipal Doshi

CEODipal Doshi

Employees

183

Employees183

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2016

Founded2016

Employees

183

Employees183

TRDA Key Statistics

Market cap

390.98M

Market cap390.98M

Price-Earnings ratio

-4.16

Price-Earnings ratio-4.16

Dividend yield

—

Dividend yield—

Average volume

179.43K

Average volume179.43K

High today

$10.45

High today$10.45

Low today

$9.89

Low today$9.89

Open price

$10.35

Open price$10.35

Volume

195.83K

Volume195.83K

52 Week high

$18.76

52 Week high$18.76

52 Week low

$4.93

52 Week low$4.93

Stock Snapshot

The current Entrada Therapeutics(TRDA) stock price is $10.23, with a market capitalization of 390.98M. The stock trades at a price-to-earnings (P/E) ratio of -4.16.

On 2025-12-29, Entrada Therapeutics(TRDA) stock traded between a low of $9.89 and a high of $10.45. Shares are currently priced at $10.23, which is +3.4% above the low and -2.1% below the high.

The Entrada Therapeutics(TRDA)'s current trading volume is 195.83K, compared to an average daily volume of 179.43K.

In the last year, Entrada Therapeutics(TRDA) shares hit a 52-week high of $18.76 and a 52-week low of $4.93.

People also own

Based on the portfolios of people who own TRDA. This list is generated using Robinhood data, and it’s not a recommendation.